Insight into the emerging role of long non-coding RNAs in BRAF inhibitor resistance in melanoma
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
Research is shedding light on the role of long non-coding RNAs in various biological processes, including cancer and disease. Some studies suggest that long non-coding RNAs may contribute to resistance to certain cancer treatments, such as BRAF inhibitors in melanoma. However, the function and significance of long non-coding RNAs appear to be complex and multifaceted, with potential implications for a range of fields beyond cancer research.
Full coverage
12345678